This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Acquisition Of Forest Laboratories, Inc. By Actavis Plc May Not Be In Shareholders' Best Interests

SAN DIEGO and NEW YORK, Feb. 18, 2014 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Forest Laboratories, Inc. (NYSE: FRX) by Actavis plc (NYSE: ACT). On February 18, 2014, the companies announced the signing of a definitive agreement pursuant to which Actavis will acquire all outstanding shares of Forest stock for $26.04 per share in cash and 0.3306 Actavis shares for each share of Forest common stock, a cash value of $89.48 per share.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO)

Is the Proposed Merger Best for Forest and Its Shareholders?

Robbins Arroyo LLP's investigation focuses on whether the board of directors at Forest is undertaking a fair process to obtain maximum value and adequately compensate Forest shareholders.  As an initial matter, the $89.48 merger consideration represents a premium of only 25.3% based on Forest's closing price on February 14, 2014.  That premium is substantially below the average one day premium of over 43% for comparable transactions in the past three years. 

In addition, on January 21, 2014, Forest released its financial results for the third quarter 2013, reporting an increase in revenues and net sales. Specifically, Forest reported a 24.9% increase in net sales to $846.8 million, from $678 million in the prior year quarter. The increase in net sales was driven by sales in the company's next generation products, which increased 59.4% compared to the third quarter of 2013. In addition, revenues for the nine months ended December 31, 2013 increased 12% to $2,554.6 million. Moreover, on February 3, 2014, Forest announced the completion of the acquisition of Aptalis which is expected to add approximately $700 million in revenue and about $0.78 per share to the company's non-GAAP EPS in the 2015 fiscal year.

Given these facts, Robbins Arroyo LLP is examining the Forest board of directors' decision to sell the company to Actavis now rather than allow shareholders to continue to participate in the company's continued success and future growth prospects. 

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs